Search Results - "Spratt, Kaye"

Refine Results
  1. 1
  2. 2

    Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury by Figley, Sarah A, Liu, Yang, Karadimas, Spyridon K, Satkunendrarajah, Kajana, Fettes, Peter, Spratt, S Kaye, Lee, Gary, Ando, Dale, Surosky, Richard, Giedlin, Martin, Fehlings, Michael G

    Published in PloS one (20-05-2014)
    “…Following spinal cord injury (SCI) there are drastic changes that occur in the spinal microvasculature, including ischemia, hemorrhage, endothelial cell death…”
    Get full text
    Journal Article
  3. 3

    An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury by Liu, Yang, Figley, Sarah, Spratt, S. Kaye, Lee, Gary, Ando, Dale, Surosky, Richard, Fehlings, Michael G

    Published in Neurobiology of disease (01-02-2010)
    “…Abstract Spinal cord injury (SCI) leads to local vascular disruption and progressive ischemia, which contribute to secondary degeneration. Enhancing…”
    Get full text
    Journal Article
  4. 4

    Treatment of traumatic brain injury using zinc-finger protein gene therapy targeting VEGF-A by Siddiq, Ishita, Park, Eugene, Liu, Elaine, Spratt, S Kaye, Surosky, Richard, Lee, Gary, Ando, Dale, Giedlin, Marty, Hare, Gregory M T, Fehlings, Michael G, Baker, Andrew J

    Published in Journal of neurotrauma (20-11-2012)
    “…Vascular endothelial growth factor (VEGF) plays a role in angiogenesis and has been shown to be neuroprotective following central nervous system trauma. In the…”
    Get more information
    Journal Article
  5. 5

    Induction of angiogenesis in a mouse model using engineered transcription factors by Giordano, Frank J, Rebar, Edward J, Huang, Yan, Hickey, Reed, Nath, Anjali K, Meoli, David, Nath, Sameer, Chen, Bingliang, Xu, Lei, Liang, Yuxin, Jamieson, Andrew C, Zhang, Lei, Spratt, S Kaye, Case, Casey C, Wolffe, Alan

    Published in Nature medicine (01-12-2002)
    “…The relationship between the structure of zinc-finger protein (ZFP) transcription factors and DNA sequence binding specificity has been extensively studied…”
    Get full text
    Journal Article
  6. 6

    A Designed Zinc-finger Transcriptional Repressor of Phospholamban Improves Function of the Failing Heart by Zhang, H Steve, Liu, Dingang, Huang, Yan, Schmidt, Stefan, Hickey, Reed, Guschin, Dmitry, Su, Haili, Jovin, Ion S, Kunis, Mike, Hinkley, Sarah, Liang, Yuxin, Hinh, Linda, Spratt, S Kaye, Case, Casey C, Rebar, Edward J, Ehrlich, Barbara, Gregory, Philip D, Giordano, Frank J

    Published in Molecular therapy (01-08-2012)
    “…Selective inhibition of disease-related proteins underpins the majority of successful drug–target interactions. However, development of effective antagonists…”
    Get full text
    Journal Article
  7. 7

    Gene Transfer of an Engineered Transcription Factor Promoting Expression of VEGF-A Protects Against Experimental Diabetic Neuropathy by PRICE, Sally A, DENT, Carolyn, TOMLINSON, David R, DURAN-JIMENEZ, Beatriz, YUXIN LIANG, LEI ZHANG, REBAR, Edward J, CASE, Casey C, GREGORY, Philip D, MARTIN, Tyler J, KAYE SPRATT, S

    Published in Diabetes (New York, N.Y.) (01-06-2006)
    “…Gene Transfer of an Engineered Transcription Factor Promoting Expression of VEGF-A Protects Against Experimental Diabetic Neuropathy Sally A. Price 1 , Carolyn…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Engineered Zinc Finger Protein–Mediated VEGF-A Activation Restores Deficient VEGF-A in Sensory Neurons in Experimental Diabetes by PAWSON, Elizabeth J, DURAN-JIMENEZ, Beatriz, SUROSKY, Richard, BROOKE, Heather E, SPRATT, S. Kaye, TOMLINSON, David R, GARDINER, Natalie J

    Published in Diabetes (New York, N.Y.) (01-02-2010)
    “…Engineered Zinc Finger Protein–Mediated VEGF-A Activation Restores Deficient VEGF-A in Sensory Neurons in Experimental Diabetes Elizabeth J. Pawson 1 , Beatriz…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors by Snyder, Richard O, Miao, Carol H, Patijn, Gijsbert A, Spratt, S. Kaye, Danos, Olivier, Nagy, Dea, Gown, Allen M, Winther, Brian, Meuse, Leonard, Cohen, Lawrence K, Thompson, Arthur R, Kay, Mark A

    Published in Nature genetics (01-07-1997)
    “…Haemophilia B, or factor IX deficiency, is a X-linked recessive disorder that occurs in about one in 25,000 males, and severely affected people are at risk for…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice by Snyder, R O, Spratt, S K, Lagarde, C, Bohl, D, Kaspar, B, Sloan, B, Cohen, L K, Danos, O

    Published in Human gene therapy (01-11-1997)
    “…Recombinant adeno-associated virus (rAAV) vectors were evaluated for gene transfer into the skeletal muscle of adult immunocompetent mice. A study using a…”
    Get more information
    Journal Article
  15. 15

    Ocular Gene Transfer with Self-Complementary AAV Vectors by Yokoi, Katsutoshi, Kachi, Shu, Zhang, H. Steve, Gregory, Philip D, Spratt, S. Kaye, Samulski, R. Jude, Campochiaro, Peter A

    “…Self-complementary AAV (scAAV) vectors have been developed to circumvent rate-limiting second-strand synthesis in single-stranded AAV vector genomes and to…”
    Get full text
    Journal Article
  16. 16

    Gene therapy for traumatic central nervous system injury and stroke using an engineered zinc finger protein that upregulates VEGF-A by D'Onofrio, Philippe M, Thayapararajah, Mahinthan, Lysko, Meghan D, Magharious, Mark, Spratt, S Kaye, Lee, Gary, Ando, Dale, Surosky, Richard, Fehlings, Michael G, Koeberle, Paulo D

    Published in Journal of neurotrauma (01-09-2011)
    “…Recent studies have identified anti-apoptotic functions for vascular endothelial growth factor (VEGF) in the central nervous system (CNS). However, VEGF…”
    Get more information
    Journal Article
  17. 17

    Selective uptake and sustained expression of AAV vectors following subcutaneous delivery by Donahue, Brian A., McArthur, James G., Spratt, S. Kaye, Bohl, Delphine, Lagarde, Catherine, Sanchez, Lisa, Kaspar, Brian A., Sloan, Barbara A., Lee, Ya Li, Danos, Olivier, Snyder, Richard O.

    Published in The journal of gene medicine (01-01-1999)
    “…Background Recombinant adeno‐associated viral (rAAV) vectors are capable of long‐term expression of secreted and intracellular proteins following delivery to…”
    Get full text
    Journal Article
  18. 18

    Isolation and characterization of the human pulmonary surfactant apoprotein gene by White, R. Tyler, Damm, Deborah, Miller, Judith, Spratt, Kaye, Schilling, James, Hawgood, Samuel, Benson, Brad, Cordell, Barbara

    Published in Nature (London) (01-09-1985)
    “…Pulmonary surfactant is a phospholipid-protein complex which serves to lower the surface tension at the air-liquid interface in the alveoli of the mammalian…”
    Get full text
    Journal Article
  19. 19
  20. 20